Published in Int J Oncol on September 01, 2006
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
20-Hydroxyvitamin D2 is a noncalcemic analog of vitamin D with potent antiproliferative and prodifferentiation activities in normal and malignant cells. Am J Physiol Cell Physiol (2010) 1.54
Melatonin membrane receptors in peripheral tissues: distribution and functions. Mol Cell Endocrinol (2012) 1.47
RORα and ROR γ are expressed in human skin and serve as receptors for endogenously produced noncalcemic 20-hydroxy- and 20,23-dihydroxyvitamin D. FASEB J (2014) 1.39
Cytochromes p450 and skin cancer: role of local endocrine pathways. Anticancer Agents Med Chem (2014) 1.20
Local melatoninergic system as the protector of skin integrity. Int J Mol Sci (2014) 1.15
Rotating night shifts and risk of skin cancer in the nurses' health study. J Natl Cancer Inst (2011) 1.08
Metabolism of melatonin and biological activity of intermediates of melatoninergic pathway in human skin cells. FASEB J (2013) 1.02
Melanocyte receptors: clinical implications and therapeutic relevance. Dermatol Clin (2007) 1.01
A new steroidal 5,7-diene derivative, 3beta-hydroxyandrosta-5,7-diene-17beta-carboxylic acid, shows potent anti-proliferative activity. Steroids (2009) 0.95
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
Melatonin and its metabolites accumulate in the human epidermis in vivo and inhibit proliferation and tyrosinase activity in epidermal melanocytes in vitro. Mol Cell Endocrinol (2014) 0.90
Expression of melatonin receptors in triple negative breast cancer (TNBC) in African American and Caucasian women: relation to survival. Breast Cancer Res Treat (2012) 0.89
The melatonin-producing system is fully functional in retinal pigment epithelium (ARPE-19). Mol Cell Endocrinol (2009) 0.83
The critical role of redox homeostasis in shikonin-induced HL-60 cell differentiation via unique modulation of the Nrf2/ARE pathway. Oxid Med Cell Longev (2012) 0.81
Neuroendocrinology of the skin: An overview and selective analysis. Dermatoendocrinol (2011) 0.81
Melatonin and human skin aging. Dermatoendocrinol (2012) 0.79
Differential effects of melatonin as a broad range UV-damage preventive dermato-endocrine regulator. Dermatoendocrinol (2011) 0.79
Melatonin combined with endoplasmic reticulum stress induces cell death via the PI3K/Akt/mTOR pathway in B16F10 melanoma cells. PLoS One (2014) 0.79
A Comparison of B16 Melanoma Cells and 3T3 Fibroblasts Concerning Cell Viability and ROS Production in the Presence of Melatonin, Tested Over a Wide Range of Concentrations. Int J Mol Sci (2013) 0.76
Circadian Dysrhythmias, Physiological Aberrations, and the Link to Skin Cancer. Int J Mol Sci (2016) 0.76
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells. Oncotarget (2017) 0.75
Neuroendocrinology of the skin. Endocr Rev (2000) 3.34
Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev (2000) 2.98
Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab (1987) 2.35
Racial pigmentation and the cutaneous synthesis of vitamin D. Arch Dermatol (1991) 2.33
Age, vitamin D, and solar ultraviolet. Lancet (1989) 1.82
The effect of standard- and high-dose epinephrine on coronary perfusion pressure during prolonged cardiopulmonary resuscitation. JAMA (1991) 1.74
Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J (2001) 1.74
What are melanocytes really doing all day long...? Exp Dermatol (2009) 1.65
Detection of proopiomelanocortin-derived antigens in normal and pathologic human skin. J Lab Clin Med (1993) 1.58
Glycosaminoglycans in histologic sections. Arch Dermatol (1987) 1.39
Production and release of proopiomelanocortin (POMC) derived peptides by human melanocytes and keratinocytes in culture: regulation by ultraviolet B. Biochim Biophys Acta (1996) 1.39
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
CRH functions as a growth factor/cytokine in the skin. J Cell Physiol (2006) 1.38
Chronic sunscreen use decreases circulating concentrations of 25-hydroxyvitamin D. A preliminary study. Arch Dermatol (1988) 1.30
Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res (1986) 1.27
Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest (1993) 1.20
Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab (1992) 1.20
Cutaneous expression of CRH and CRH-R. Is there a "skin stress response system?". Ann N Y Acad Sci (1999) 1.18
Metabolism of progesterone to DOC, corticosterone and 18OHDOC in cultured human melanoma cells. FEBS Lett (1999) 1.17
Active steroidogenesis in the normal rat skin. Biochim Biophys Acta (2000) 1.17
A characterization of hypothalamic-pituitary-adrenal axis function during and after human cardiac arrest. Crit Care Med (1993) 1.12
Celiac disease-associated autoimmune endocrinopathies. Clin Diagn Lab Immunol (2001) 1.10
UV light and MSH receptors. Ann N Y Acad Sci (1999) 1.09
Pleiotropic effects of corticotropin releasing hormone on normal human skin keratinocytes. In Vitro Cell Dev Biol Anim (2001) 1.07
Kinetic and thermodynamic studies of the conversion of previtamin D3 to vitamin D3 in human skin. J Biol Chem (1993) 1.07
Characterization of corticotropin-releasing hormone (CRH) in human skin. J Clin Endocrinol Metab (1998) 1.06
What are subcutaneous adipocytes really good for? Exp Dermatol (2007) 1.06
Mast cell involvement in murine hair growth. Dev Biol (1994) 1.06
Adrenomedullary response to maximal stress in humans. Am J Med (1984) 1.04
What's the use of generating melanin? Exp Dermatol (1999) 1.04
Corticotropin releasing hormone and related peptides can act as bioregulatory factors in human keratinocytes. In Vitro Cell Dev Biol Anim (2000) 1.04
On the potential role of proopiomelanocortin in skin physiology and pathology. Mol Cell Endocrinol (1993) 1.04
Malignant melanoma. Arch Pathol Lab Med (2001) 1.04
Compensation for the interracial variance in the cutaneous synthesis of vitamin D. J Lab Clin Med (1995) 1.03
On the role of the corticotropin-releasing hormone signalling system in the aetiology of inflammatory skin disorders. Br J Dermatol (2009) 1.02
The skin produces urocortin. J Clin Endocrinol Metab (2000) 1.01
Melatonin increases survival of HaCaT keratinocytes by suppressing UV-induced apoptosis. J Pineal Res (2006) 1.01
Modification of melanogenesis in cultured human melanoma cells. In Vitro Cell Dev Biol Anim (2000) 1.00
Hair cycle-dependent expression of corticotropin-releasing factor (CRF) and CRF receptors in murine skin. FASEB J (1998) 0.99
Steroidogenesis in the human skin: 21-hydroxylation in cultured keratinocytes. J Steroid Biochem Mol Biol (2001) 0.99
In vivo threshold for cutaneous synthesis of vitamin D3. J Lab Clin Med (1989) 0.98
Inhibition of mouse melanoma cell proliferation by corticotropin-releasing hormone and its analogs. Anticancer Res (2001) 0.98
Molecular pathology of soft tissue and bone tumors. A review. Arch Pathol Lab Med (1999) 0.98
Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med (1995) 0.97
Adrenal insufficiency in high-risk surgical ICU patients. Chest (2001) 0.97
Effect of CRF and related peptides on calcium signaling in human and rodent melanoma cells. FEBS Lett (1998) 0.97
Liquid chromatography-mass spectrometry detection of corticotropin-releasing hormone and proopiomelanocortin-derived peptides in human skin. J Clin Endocrinol Metab (2000) 0.96
Skin histoculture assay for studying the hair cycle. In Vitro Cell Dev Biol (1993) 0.95
Use of topical sunscreen for the evaluation of regional synthesis of vitamin D3. J Am Acad Dermatol (1990) 0.95
Plasma catecholamine and serum cortisol responses to experimental cardiac arrest in dogs. Am J Physiol (1987) 0.94
Spatiotemporal expression, distribution, and processing of POMC and POMC-derived peptides in murine skin. J Histochem Cytochem (2000) 0.93
The measurement of intestinal calcium absorption by external radioisotope counting: application to study of nephrolithiasis. Clin Sci (1970) 0.93
Ultrasound detection and identification of cosmetic fillers in the skin. J Eur Acad Dermatol Venereol (2011) 0.93
Production of POMC, CRH-R1, MC1, and MC2 receptor mRNA and expression of tyrosinase gene in relation to hair cycle and dexamethasone treatment in the C57BL/6 mouse skin. J Invest Dermatol (1997) 0.93
Alkaline phosphatase (EC 3.1.3.1) in serum is inhibited by physiological concentrations of inorganic phosphate. J Clin Endocrinol Metab (1998) 0.93
Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes. J Pineal Res (2007) 0.92
Effect of obesity on the clinical and hormonal characteristics of the polycystic ovary syndrome. J Reprod Med (1994) 0.92
Anthracycline drug targeting: cytoplasmic versus nuclear--a fork in the road. Drug Resist Updat (2001) 0.91
The fate of hair follicle melanocytes during the hair growth cycle. J Investig Dermatol Symp Proc (1999) 0.91
Identification and characterization of two isozymic forms of arylamine N-acetyltransferase in Syrian hamster skin. J Invest Dermatol (1993) 0.90
Corticotropin-releasing hormone triggers differentiation in HaCaT keratinocytes. Br J Dermatol (2005) 0.90
Plasma chromogranin A as a marker of sympathochromaffin activity in humans. Am J Physiol (1991) 0.89
Ultraviolet B and melanocyte-stimulating hormone (MSH) stimulate mRNA production for alpha MSH receptors and proopiomelanocortin-derived peptides in mouse melanoma cells and transformed keratinocytes. J Invest Dermatol (1995) 0.89
Sex steroid levels during treatment of endometriosis. Obstet Gynecol (1979) 0.88
Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. J Clin Endocrinol Metab (1985) 0.88
Sonography in pathologies of scalp and hair. Br J Radiol (2012) 0.88
Cutaneous immunomodulation and coordination of skin stress responses by alpha-melanocyte-stimulating hormone. Ann N Y Acad Sci (1998) 0.88
Spinal meningeal AVM supplied from the internal iliac artery associated with tethered cord syndrome in an adult: case report. J Can Assoc Radiol (1983) 0.87
Choriocarcinoma presenting as a cutaneous metastasis. J Cutan Pathol (1995) 0.87
Melanotropic activity of gamma MSH peptides in melanoma cells. Life Sci (1992) 0.87
The tissue distribution and pharmacokinetics of saccharin in the rat. Toxicol Appl Pharmacol (1980) 0.86
Spectrum of endocrine abnormalities associated with acanthosis nigricans. Am J Med (1987) 0.86
The proopiomelanocortin system in cutaneous neuroimmunomodulation. An introductory overview. Ann N Y Acad Sci (1999) 0.86
Down-regulation of the expression of O-acetyl-GD3 by the O-acetylesterase cDNA in hamster melanoma cells: effects on cellular proliferation, differentiation, and melanogenesis. J Neurochem (1999) 0.84
Amelioration of adriamycin toxicity through modification of drug-DNA binding properties. Cancer Treat Rev (1987) 0.84
The skin POMC system (SPS). Leads and lessons from the hair follicle. Ann N Y Acad Sci (1999) 0.84
Identification of beta-endorphin, alpha-MSH and ACTH peptides in cultured human melanocytes, melanoma and squamous cell carcinoma cells by RP-HPLC. Exp Dermatol (1998) 0.83
Celiac disease and hypoparathyroidism: cross-reaction of endomysial antibodies with parathyroid tissue. Clin Diagn Lab Immunol (1996) 0.83
Microassay of phosphate provides a general method for measuring the activity of phosphatases using physiological, nonchromogenic substrates such as lysophosphatidic acid. Anal Biochem (2001) 0.83
N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells. Oncol Res (1992) 0.83
Developmentally regulated expression of alpha-MSH and MC-1 receptor in C57BL/6 mouse skin suggests functions beyond pigmentation. Ann N Y Acad Sci (1999) 0.82